BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22995329)

  • 1. The pluripotent renal stem cell regulator SIX2 is activated in renal neoplasms and influences cellular proliferation and migration.
    Senanayake U; Koller K; Pichler M; Leuschner I; Strohmaier H; Hadler U; Das S; Hoefler G; Guertl B
    Hum Pathol; 2013 Mar; 44(3):336-45. PubMed ID: 22995329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lim1, an embryonal transcription factor, is absent in multicystic renal dysplasia, but reactivated in nephroblastomas.
    Guertl B; Senanayake U; Nusshold E; Leuschner I; Mannweiler S; Ebner B; Hoefler G
    Pathobiology; 2011; 78(4):210-9. PubMed ID: 21778788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of promoter methylation and expression of SIX2 as a diagnostic and prognostic biomarker in Wilms' tumor.
    Song D; Yue L; Wu G; Ma S; Guo L; Yang H; Liu Q; Zhang D; Xia Z; Wang L; Zhang J; Zhao W; Guo F; Wang J
    Tumour Biol; 2015 Sep; 36(10):7591-8. PubMed ID: 25921281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and promoter methylation of SIX2 gene in peripheral blood of pediatric patients with nephroblastoma].
    Song DJ; Yue LF; Yang HY; Jia XY; Zhang JJ; Xu YL; Guo F; Wang JX
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(24):1876-80. PubMed ID: 24124738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
    Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
    J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plexin B1 is downregulated in renal cell carcinomas and modulates cell growth.
    Gómez Román JJ; Garay GO; Saenz P; Escuredo K; Sanz Ibayondo C; Gutkind S; Junquera C; Simón L; Martínez A; Fernández Luna JL; Val-Bernal JF
    Transl Res; 2008 Mar; 151(3):134-40. PubMed ID: 18279812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
    Rodins K; Cheale M; Coleman N; Fox SB
    Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms' tumor.
    Murphy AJ; Pierce J; de Caestecker C; Taylor C; Anderson JR; Perantoni AO; de Caestecker MP; Lovvorn HN
    J Pediatr Surg; 2012 Jun; 47(6):1239-49. PubMed ID: 22703800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.
    Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mochizuki S; Ikeda T; Mukai M; Okada Y
    J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma.
    Cho M; Uemura H; Kim SC; Kawada Y; Yoshida K; Hirao Y; Konishi N; Saga S; Yoshikawa K
    Br J Cancer; 2001 Aug; 85(4):563-7. PubMed ID: 11506497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephroblastomas show low expression of microR-204 and high expression of its target, the oncogenic transcription factor MEIS1.
    Koller K; Pichler M; Koch K; Zandl M; Stiegelbauer V; Leuschner I; Hoefler G; Guertl B
    Pediatr Dev Pathol; 2014; 17(3):169-75. PubMed ID: 24617557
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Wu Y; Song T; Liu M; He Q; Chen L; Liu Y; Ni D; Liu J; Hu Y; Gu Y; Li Q; Zhou Q; Xie Y
    DNA Cell Biol; 2019 Jul; 38(7):700-707. PubMed ID: 31090452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of malignant renal stem cells is associated with epigenetic changes in normal renal progenitor genes.
    Metsuyanim S; Pode-Shakked N; Schmidt-Ott KM; Keshet G; Rechavi G; Blumental D; Dekel B
    Stem Cells; 2008 Jul; 26(7):1808-17. PubMed ID: 18467665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
    Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
    Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis.
    Peters I; Rehmet K; Wilke N; Kuczyk MA; Hennenlotter J; Eilers T; Machtens S; Jonas U; Serth J
    Mol Cancer; 2007 Jul; 6():49. PubMed ID: 17634119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the glucocorticoid receptor in renal cell neoplasms: an immunohistochemical and quantitative reverse transcriptase polymerase chain reaction study.
    Yakirevich E; Matoso A; Sabo E; Wang LJ; Tavares R; Meitner P; Morris DJ; Pareek G; Delellis RA; Resnick MB
    Hum Pathol; 2011 Nov; 42(11):1684-92. PubMed ID: 21531004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibulin-1 is down-regulated through promoter hypermethylation and suppresses renal cell carcinoma progression.
    Xiao W; Wang J; Li H; Guan W; Xia D; Yu G; Xiao H; Lang B; Ma X; Liu J; Zhang X; Ye Z; Xu H
    J Urol; 2013 Jul; 190(1):291-301. PubMed ID: 23391467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.
    Lv D; Zhao W; Dong D; Qian XP; Zhang Y; Tian XJ; Zhang J
    Eur J Cancer; 2011 Sep; 47(13):2068-76. PubMed ID: 21600761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response.
    Balamurugan K; Luu VD; Kaufmann MR; Hofmann VS; Boysen G; Barth S; Bordoli MR; Stiehl DP; Moch H; Schraml P; Wenger RH; Camenisch G
    Oncogene; 2009 Sep; 28(37):3274-85. PubMed ID: 19581925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and cytoplasmic localization of SAM68 is a significant and independent prognostic marker for renal cell carcinoma.
    Zhang Z; Li J; Zheng H; Yu C; Chen J; Liu Z; Li M; Zeng M; Zhou F; Song L
    Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2685-93. PubMed ID: 19755649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.